HomeBody MapPeptidesCalculator
Catalog4 refs

Plecanatide

OtherResearch use only
Educational use only. Not medical advice. Verify all information with primary sources and a licensed clinician before use.
Half-life
2
Uses
3 mg
Typical
Body Map
Loading 3D model…
Overview

Plecanatide is built as an analog of uroguanylin, a natural peptide your intestine already makes to manage fluid balance. It activates guanylate cyclase-C receptors on the gut lining, which raises cyclic GMP inside those cells. That triggers chloride and bicarbonate secretion into the intestine and blocks sodium reabsorption, so water is drawn into the bowel, softening stool and speeding transit. One proposed difference from linaclotide is that its activity is more strongly switched on in the slightly acidic environment of the upper small intestine, which the manufacturer argues may shape where it acts, though this is a positioning claim more than a proven clinical advantage. Like other GC-C agonists it is minimally absorbed and works locally.

Primary Uses
Chronic idiopathic constipation (CIC)
Irritable bowel syndrome with constipation (IBS-C)
Protocol Reference
Dose
3 mg once daily
Frequency
Once daily
Route
Oral tablet with or without food
Evidence
FDA Approved
Research References· 2
FDA Approved Labeling \- Prescribed dose ↗
PubMedPMID 28134631#### Duration
https://pubmed.ncbi.nlm.nih.gov/30550753/
PubMedPMID 30550753- [https://pmc.ncbi.nlm.nih.gov/articles/PMC10464888/](https://pmc.ncbi.nlm.nih.gov/articles/PMC10464888/)
Research Models
Human
Also in Other
Other
Abaloparatide
Osteoporosis treatment · Postmenopausal Osteoporosis
Other
ACE-031
Muscle Hypertrophy · Muscular Dystrophy
Other
ACTH (Cosyntropin)
Diagnostic tool to test adrenal gland function · Assess adrenal reserve
Other
Adrenocorticotropic hormone (ACTH)
adrenal insufficiency diagnosis · adrenal insufficiency treatment
Compare